Search by Drug Name or NDC
NDC 24208-0022-90 Methazolamide 25 mg/1 Details
Methazolamide 25 mg/1
Methazolamide is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Bausch & Lomb Incorporated. The primary component is METHAZOLAMIDE.
MedlinePlus Drug Summary
Methazolamide is used to treat glaucoma (a condition in which increased pressure in the eye can lead to gradual loss of vision). Methazolamide is in a class of medications called carbonic anhydrase inhibitors. It works by decreasing the pressure in the eye.
Related Packages: 24208-0022-90Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Methazolamide
Product Information
| NDC | 24208-0022 |
|---|---|
| Product ID | 24208-022_65e6efe6-26f9-4d78-81f1-296cb4381353 |
| Associated GPIs | |
| GCN Sequence Number | 008168 |
| GCN Sequence Number Description | methazolamide TABLET 25 MG ORAL |
| HIC3 | R1E |
| HIC3 Description | CARBONIC ANHYDRASE INHIBITORS |
| GCN | 34741 |
| HICL Sequence Number | 003643 |
| HICL Sequence Number Description | METHAZOLAMIDE |
| Brand/Generic | Generic |
| Proprietary Name | Methazolamide |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | methazolamide |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | TABLET |
| Route | ORAL |
| Active Ingredient Strength | 25 |
| Active Ingredient Units | mg/1 |
| Substance Name | METHAZOLAMIDE |
| Labeler Name | Bausch & Lomb Incorporated |
| Pharmaceutical Class | n/a |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA207438 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 24208-0022-90 (24208002290)
| NDC Package Code | 24208-022-90 |
|---|---|
| Billing NDC | 24208002290 |
| Package | 90 TABLET in 1 BOTTLE (24208-022-90) |
| Marketing Start Date | 2020-10-02 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |